About the Authors
- Vasee S Moorthy
-
Affiliations Medical Research Council Laboratories, Banjul, Gambia, Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Egeruan B Imoukhuede
-
Affiliation Medical Research Council Laboratories, Banjul, Gambia
- Paul Milligan
-
Affiliation Medical Research Council Laboratories, Banjul, Gambia
- Kalifa Bojang
-
Affiliation Medical Research Council Laboratories, Banjul, Gambia
- Sheila Keating
-
Affiliation Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom
- Pauline Kaye
-
Affiliation Medical Research Council Laboratories, Banjul, Gambia
- Margaret Pinder
-
Affiliation Medical Research Council Laboratories, Banjul, Gambia
- Sarah C Gilbert
-
Affiliation Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
- Gijs Walraven
-
Affiliation Medical Research Council Laboratories, Banjul, Gambia
- Brian M Greenwood
-
Affiliation London School of Hygiene and Tropical Medicine, London, United Kingdom
- Adrian S. V Hill
-
Affiliations Centre for Clinical Vaccinology and Tropical Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Churchill Hospital, Oxford, United Kingdom, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Competing Interests
VSM, EBI, PM, KB, SK, PK, MP, SCG, GW, and BMG have declared that no competing interests exist. AVSH is a co-founder and equity holder in Oxxon Therapeutics, a company developing prime-boost therapeutic vaccines.
Author Contributions
VSM wrote the manuscript and clinical trial protocol, designed the case report form, and supervised recruitment, vaccination, laboratory work, and follow-up. EBI supervised recruitment, vaccination, and follow-up. PM analysed the data and helped plan the trial. KB helped plan the trial. SK conducted the immunology analysis. PK was the data manager. MP helped laboratory supervision and planning of the trial. SCG conducted preclinical development and some quality control of the vaccines. GW helped with recruitment and planning of the trial. BMG helped plan the trial. AVSH supervised development of the malaria vaccines and the immunology assays and helped plan and report the trial.